MedPath

A clinical trial to study the effects of three drugs, desogestrel with ethinyl oestradiol, cyproterone acetate with ethinyl oestradiol and drospirenone with ethinyl oestradiol in patients with polycystic ovary syndrome.

Not Applicable
Registration Number
CTRI/2010/091/000332
Lead Sponsor
DR.SUDHINDRA MOHAN BHATTACHARYA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
150
Inclusion Criteria

women with oligomenorrhoea diagnosed as having Polycystic ovary syndrome as per the Rotterdam criteria 2003 ; age - from minimum gynaecological age of 3 years (age since menarche) to 35 years .

Exclusion Criteria

secondary causes of hyperandrogenism like gross hypothyroidism, hyperprolactinaemia, Cushing syndrome, late onset congenital adrenal hyperplasia; contraindications of oral pill therapy; severe liver disease, renal disease, cardiac disease; those who had already taken oral pills in the preceding 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath